We’ve teamed up with Kilter Rewards for a virtual wellness challenge where YOU can help raise essential funding by staying active! Your participation will contribute
Five years ago, Raleigh, North Carolina’s own Chris Combs, a loving husband and father of three young children, was diagnosed out of nowhere with ALS.
Earlier this month, we reached a big regulatory milestone: Prosetin received Orphan Drug Designation, or orphan status, for the treatment of ALS from the Food
In our biweekly webinars, we have described the process of developing Prosetin—the first potential investigational drug to emerge from The Project ALS Therapeutics Core at
The Wasserman family has experienced first-hand the devastating effects of neurodegenerative diseases: Sandra Wasserman lost her beloved husband to Parkinson’s disease, and her son to
Last year, Project ALS launched The Project ALS Therapeutics Core at Columbia (THE CORE), a 3-year, $6.3M initiative toward the first meaningful therapies for ALS.
Project ALS is encouraged by the introduction of two bills that aim to provide people with ALS faster, more robust access to experimental therapies. These
Dear Friends, Project ALS is acutely aware of the unimaginable circumstances that Americans and people around the world are now facing. Our hearts, souls, and
Project ALS is excited to launch a new research partnership with the Medidata Institute targeting new, actionable insights into ALS disease progression and subtypes. Medidata
Project ALS is proud to once again be a bronze level charity sponsor for the 2020 TCS New York City Marathon. Thanks to the efforts
“Jaci is blazing a path that hopefully will not just cure her but set a course of treatment for countless others.” – Lori Hermstad, mother.
Give the gift of research this holiday season. Donate now.
